Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
This study is currently recruiting participants.
Verified May 2013
by Centre Hospitalier Universitaire de Québec, CHU de Québec
Study NCT01352234 Information provided by Centre Hospitalier Universitaire de Québec, CHU de Québec
First Received on April 1, 2011. Last Updated on May 21, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pre-Eclampsia
Fetal Growth Retardation
Prematurity of Fetus
Placental Insufficiency
Additional conditions recognized in this trial
Eclampsia
Hypertension, Pregnancy-Induced
More general conditions related to this trial
Cardiovascular Diseases
Fetal Diseases
Growth Disorders
Hypertension
Pathologic Processes
Placenta Diseases
Pregnancy Complications
Vascular Diseases
Interventions listed in this trial
Acetylsalicylic acid (ASA) 160 mg
Acetylsalicylic acid (ASA) 80 mg
Additional drug interventions recognized in this trial
Aspirin
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antipyretics
Antirheumatic Agents
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Centre Hospitalier Universitaire de Québec, CHU de Québec
Back to top of Main Content
